Physician profile
Angela N Harvey
NPI 1659813517
$2,897.38
in general payments reported to CMS, 2019-2025
21 companies · $310 in 2025
The $310 reported for 2025 was more than what 87% of Women'S Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $274 · 2022: $355 · 2023: $1,660 · 2024: $297 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,300 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,299.89 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $968.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,219.61 | 2023-2025 | Myfembree |
| Abbvie INC. | $269.80 | 2021-2023 | |
| Astellas Pharma US INC | $224.94 | 2023-2025 | Veozah |
| Myovant Sciences INC. | $212.97 | 2021-2022 | |
| Biogen, INC. | $173.67 | 2024-2025 | Zurzuvae |
| Organon LLC | $165.44 | 2021-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $144.30 | 2021-2023 | Myosure Tissue Removal Device, Novasure, Aptima |
| Mayne Pharma Commercial LLC | $144.14 | 2022-2024 | |
| Coopersurgical, INC. | $60.34 | 2024 | Paragard T 380a |
| Mylan Pharmaceuticals INC. | $47.44 | 2021 | |
| Daiichi Sankyo INC. | $31.12 | 2021 | |
| Smith+Nephew, INC. | $29.14 | 2024-2025 | Pico 7, Pico 14, "Acticoat 4"" X 4""" |
| Pfizer INC. | $27.39 | 2024 | |
| Ethicon US, LLC | $25.68 | 2023 | Ethicon, Dermabond, Stratafix |
| Baxter Healthcare | $21.90 | 2024 | Tisseel |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $20.29 | 2023 | Accrufer |
| Exact Sciences Corporation | $17.72 | 2025 | Cologuard Collection Kit |
| Becton, Dickinson and Company | $17.29 | 2025 | Bd Onclarity |
| Agile Therapeutics, INC. | $15.80 | 2023 | Twirla |
| Medicem INC. | $14.89 | 2023 | |
| Therapeuticsmd, INC. | $13.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Harvey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.